[HTML][HTML] Transcatheter closure of perimembranous ventricular septal defect using a novel fully bioabsorbable occluder: multicenter randomized controlled trial
S Wang, Z Li, Y Wang, T Zhao, X Mo, T Fan, J Li, T You… - Science Bulletin, 2023 - Elsevier
Although the use of bioabsorbable occluder is expected to reduce the risk of metal occluder-
related complications, it has not been approved due to incomplete degradation and new
complications. Novel fully bioabsorbable occluders were designed to overcome such
limitations. The aim of this study was to investigate the efficacy and safety of a fully
biodegradable occluder in patients with ventricular septal defects. 125 patients with
perimembranous ventricular septal defect (VSD) larger than 3 mm were screened from April …
related complications, it has not been approved due to incomplete degradation and new
complications. Novel fully bioabsorbable occluders were designed to overcome such
limitations. The aim of this study was to investigate the efficacy and safety of a fully
biodegradable occluder in patients with ventricular septal defects. 125 patients with
perimembranous ventricular septal defect (VSD) larger than 3 mm were screened from April …